Additional bipolar indication for Seroquel

Seroquel and Seroquel XL (quetiapine) have been approved for the treatment of major depressive episodes in adults with bipolar disorder, in addition to the products' existing indications for schizophrenia and manic episodes. The new indication, for which the maximum daily dose is 600mg, carries a black triangle to indicate that all adverse events should
be reported.

View Seroquel drug record

Further information: AstraZeneca

To sign up for the MIMS monthly news update, register at

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

A woman leans on a desk holding her stomach in pain.

Draft NICE approval for new fibroid treatment

Around 4500 women in England and Wales will be eligible...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...